December 7, 2017 Bio/Pharma/CRO PR/Corporate

Phase III IMpower150 study showed Tecentriq (atezolizumab) and Avastin (bevacizumab) plus chemotherapy reduced the risk of disease worsening or death by 38 percent for people with a type of advanced lung cancer

Basel, 07 December 2017 Phase III IMpower150 study showed Tecentriq (atezolizumab) and Avastin (bevacizumab) plus chemotherapy reduced the risk of disease worsening or death by 38 percent for people with a type of advanced lung cancer First Phase III combination trial of a cancer immunotherapy to show improvement in progression-free survival as an initial treatment... Read more

December 6, 2017 Environ, Ag./Food & Bev PR/Corporate

Neogen announces Bradley retirement

CONTACT: Steve Quinlan, Vice President & CFO, 517/372-9200 LANSING, Mich., Dec. 6, 2017 — Neogen Corporation (NASDAQ: NEOG) announced today that Ed Bradley has advised the company of his intentions to retire to pursue his personal interests. Bradley, vice president of Neogen’s Food Safety division, began his career with Neogen 23 years ago, and for the... Read more

December 4, 2017 PR/Corporate

Nikon Instruments Showcases Latest Biological Imaging Instruments at the American Society for Cell Biology Annual Meeting

MELVILLE, N.Y., Dec. 04, 2017 (GLOBE NEWSWIRE) — Nikon Instruments Inc., innovator of advanced optical instruments, is exhibiting the latest developments in biological imaging systems at the American Society for Cell Biology Annual Meeting 2017 in Philadelphia this week. From a new HD 1K resonant scanner for fast confocal imaging to refined objectives and fully-incubated... Read more

November 30, 2017 PR/Corporate Process Analytical Instr. Uncategorized

MKS Instruments Makes a Voluntary $50 Million Prepayment on its Term Loan

ANDOVER, Mass., Nov. 30, 2017 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ:MKSI), a global provider of technologies that enable advanced processes and improve productivity, today made a $50 million voluntary principal prepayment on its term loan. This prepayment is in addition to voluntary principal prepayments of $175 million made in the first three quarters of... Read more

November 28, 2017 Lab Top-10 Licensing, IP, and Legal PR/Corporate

Danaher Announces Leadership Appointment

WASHINGTON, Nov. 28, 2017 /PRNewswire/ — Danaher Corporation (NYSE: DHR) announced today that its Board of Directors is appointing Joakim Weidemanis to the position of Executive Vice President of Danaher Corporation, with responsibility for the Company’s Product Identification and Water Quality platforms. With this appointment, Mr. Weidemanis will become an Executive Officer of the Company.... Read more

November 28, 2017 Microscopy PR/Corporate

Consolidated Financial Statements for the Second Quarter Ended September 30, 2017

2Q Results, September 30, 2017（PDF）    This article is translated from press release in Japanese for your convenience. Forward-Looking StatementsStatements in this news release, other than those based on historical fact, concerning the current plans, prospects, strategies and expectations of the Company and its Group represent forecasts of future results. While such statements are based... Read more

November 28, 2017 Clinical Research/Diagn. Life Science Tools PR/Corporate

Bio-Rad Authorizes New $250 Million Share Repurchase Program

HERCULES, Calif — November 28, 2017 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, today announced that its board of directors has authorized a new share repurchase program, granting the Company authority to repurchase, on a discretionary basis, up to $250 million of the outstanding... Read more

November 24, 2017 Cell Analysis Tools M&A, Partnerships PR/Corporate

Sphere Fluidics and Geneva Biotech receive Eurostars genome editing grant

€1.6 million grant will support ‘precise docking of very large DNA cargoes in genomes’ project Cambridge, UK, and Geneva, Switzerland, 27 November 2017: Sphere Fluidics, a company providing single cell analysis systems underpinned by its patented picodroplet technology, and Geneva Biotech, an EMBL spin-out developing world-class viral and non-viral DNA delivery systems, have received a... Read more

November 22, 2017 Environ, Ag./Food & Bev Lab Top-10 PR/Corporate

Illumina to Webcast Upcoming Investor Conference Presentation

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference, and invites investors to participate via webcast. Citi Global Healthcare Conference, New York, NY on December 7, 2017 at 11:45 am Eastern Time. The webcast can be accessed in the Investor Relations section of Illumina’s web site under... Read more